APA

Chevallier P., Labopin M., Milpied N., Bilger K., Socié G., Yakoub-Agha I., Michallet M., Bulabois C., Maury S., Beguin Y., Bay J., Blaise D., Maillard N., Guillerm G., Daguindeau E., Raus N. & Mohty M. (20150702). Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). : Bone marrow transplantation.

Chicago

Chevallier P, Labopin M, Milpied N, Bilger K, Socié G, Yakoub-Agha I, Michallet M, Bulabois C-E, Maury S, Beguin Y, Bay J-O, Blaise D, Maillard N, Guillerm G, Daguindeau E, Raus N and Mohty M. 20150702. Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). : Bone marrow transplantation.

Harvard

Chevallier P., Labopin M., Milpied N., Bilger K., Socié G., Yakoub-Agha I., Michallet M., Bulabois C., Maury S., Beguin Y., Bay J., Blaise D., Maillard N., Guillerm G., Daguindeau E., Raus N. and Mohty M. (20150702). Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). : Bone marrow transplantation.

MLA

Chevallier P, Labopin M, Milpied N, Bilger K, Socié G, Yakoub-Agha I, Michallet M, Bulabois C-E, Maury S, Beguin Y, Bay J-O, Blaise D, Maillard N, Guillerm G, Daguindeau E, Raus N and Mohty M. Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). : Bone marrow transplantation. 20150702.